Child and adolescent immunizations: selected review of recent US recommendations and literature

Carol M Kao1, Rebecca J Schneyer, Joseph A Bocchini

  • 1aDivision of General Pediatrics, Steven and Alexandra Cohen Children's Medical Center, North Shore-Long Island Jewish Health System, New Hyde Park, New York bDepartment of Pediatrics, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA.

Insights

Childhood immunizations significantly reduce illness and death in children. Ongoing research and adherence to guidelines are crucial for optimizing vaccine coverage and protecting adolescents against preventable diseases.

Area of Science:

  • Pediatric Infectious Diseases
  • Vaccinology
  • Public Health

Background:

  • Childhood vaccination has historically reduced pediatric morbidity and mortality.
  • Recent advancements focus on expanding vaccine use and developing new immunizations.
  • Vaccine safety and immunogenicity data inform national guidelines.

Purpose of the Study:

  • To summarize current research and recommendations for childhood and adolescent immunizations.
  • To highlight the importance of vaccine uptake and adherence to guidelines.
  • To review key vaccines including influenza, meningococcal, and HPV.

Main Methods:

  • Review of recent publications and recommendations on pediatric vaccines.
  • Analysis of data on vaccine safety, immunogenicity, uptake, and cost-effectiveness.
  • Focus on specific vaccines: influenza, meningococcal conjugate, DTaP, pneumococcal conjugate, and HPV.

Main Results:

  • Vaccine research confirms safety and efficacy in diverse pediatric populations, influencing guidelines.
  • Studies underscore the importance of vaccine uptake for public health.
  • Specific vaccines reviewed include influenza, meningococcal conjugate, DTaP, pneumococcal conjugate, and HPV.

Conclusions:

  • Continued research in childhood and adolescent vaccinations is essential for refining future guidelines.
  • Optimizing protection against vaccine-preventable diseases requires ongoing efforts from providers and parents.
  • Enhancing vaccination coverage is key to safeguarding children and adolescents.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
44.1K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408